Biocon Generics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOCON GENERICS, and what generic and branded alternatives to BIOCON GENERICS drugs are available?
BIOCON GENERICS has one approved drug.
Summary for Biocon Generics
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Biocon Generics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocon Generics | TRIAMTERENE | triamterene | CAPSULE;ORAL | 214768-002 | Jul 6, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Biocon Generics | TRIAMTERENE | triamterene | CAPSULE;ORAL | 214768-001 | Jul 6, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
